Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - PubMed (original) (raw)

Practice Guideline

. 2013 Oct:24 Suppl 6:vi24-32.

doi: 10.1093/annonc/mdt333.

Affiliations

• PMID: 24078660
• DOI: 10.1093/annonc/mdt333

Free article

Practice Guideline

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

J A Ledermann et al. Ann Oncol. 2013 Oct.

Free article

Erratum in

• Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
  Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C; ESMO Guidelines Working Group. Ledermann JA, et al. Ann Oncol. 2018 Oct 1;29(Suppl 4):iv259. doi: 10.1093/annonc/mdy157. Ann Oncol. 2018. PMID: 30285216 No abstract available.

No abstract available

PubMed Disclaimer

Similar articles

• Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
  Colombo N, Peiretti M, Parma G, Lapresa M, Mancari R, Carinelli S, Sessa C, Castiglione M; ESMO Guidelines Working Group. Colombo N, et al. Ann Oncol. 2010 May;21 Suppl 5:v23-30. doi: 10.1093/annonc/mdq244. Ann Oncol. 2010. PMID: 20555088 No abstract available.
• Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
  Aebi S, Castiglione M; ESMO Guidelines Working Group. Aebi S, et al. Ann Oncol. 2009 May;20 Suppl 4:21-3. doi: 10.1093/annonc/mdp117. Ann Oncol. 2009. PMID: 19454452 Review. No abstract available.
• Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
  Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, Cardoso F; ESMO Guidelines Working Group. Senkus E, et al. Ann Oncol. 2013 Oct;24 Suppl 6:vi7-23. doi: 10.1093/annonc/mdt284. Epub 2013 Aug 22. Ann Oncol. 2013. PMID: 23970019 No abstract available.
• Epithelial ovarian cancer.
  Al-Niaimi AN, Ahmed M, Petersen CB. Al-Niaimi AN, et al. Obstet Gynecol Clin North Am. 2012 Jun;39(2):269-83. doi: 10.1016/j.ogc.2012.03.003. Obstet Gynecol Clin North Am. 2012. PMID: 22640715 No abstract available.
• An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis.
  Chung C, Lee R. Chung C, et al. J Oncol Pharm Pract. 2017 Sep;23(6):454-469. doi: 10.1177/1078155216657165. Epub 2016 Jun 29. J Oncol Pharm Pract. 2017. PMID: 27357817 Review.

Cited by

• Chemotherapy drug potency assessment method of ovarian cancer cells by digital holography microscopy.
  Liu Y, Xiao W, Zhang H, Xin L, Li X, Pan F. Liu Y, et al. Biomed Opt Express. 2022 Jul 27;13(8):4370-4385. doi: 10.1364/BOE.465149. eCollection 2022 Aug 1. Biomed Opt Express. 2022. PMID: 36032571 Free PMC article.
• A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer.
  Salminen L, Braicu EI, Lääperi M, Jylhä A, Oksa S, Hietanen S, Sehouli J, Kulbe H, Bois AD, Mahner S, Harter P, Carpén O, Huhtinen K, Hynninen J, Hilvo M. Salminen L, et al. Cancers (Basel). 2021 Apr 7;13(8):1764. doi: 10.3390/cancers13081764. Cancers (Basel). 2021. PMID: 33917079 Free PMC article.
• Anti-angiogenic agents in ovarian cancer: past, present, and future.
  Monk BJ, Minion LE, Coleman RL. Monk BJ, et al. Ann Oncol. 2016 Apr;27 Suppl 1(Suppl 1):i33-i39. doi: 10.1093/annonc/mdw093. Ann Oncol. 2016. PMID: 27141068 Free PMC article. Review.
• IGFBP3 inhibits angiogenesis through intracellular regulation of THBS1 expression.
  Shih HJ, Chen CL, Torng PL. Shih HJ, et al. Am J Cancer Res. 2020 Jun 1;10(6):1728-1744. eCollection 2020. Am J Cancer Res. 2020. PMID: 32642286 Free PMC article.
• The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC).
  Malgundkar SH, Tamimi Y. Malgundkar SH, et al. Hum Genet. 2024 Feb;143(2):107-124. doi: 10.1007/s00439-023-02635-0. Epub 2024 Jan 26. Hum Genet. 2024. PMID: 38276976 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal